In conclusion, genetic variation in DDAH1 and DDAH2 genes was found to be strongly and significantly associated with serum ADMA levels in patients with type 2 diabetes, especially in those without retinopathy. This evidence concerns the gene DDAH1 and type 2 diabetes mellitus.